同时性食管癌与头颈癌患者全身炎症反应标志物的预后意义
本研究连续纳入717例新诊断头颈鳞状细胞癌(HNSCC)并接受治疗前食管内镜筛查的患者,分析治疗前中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和淋巴细胞与单核细胞比值(LMR)与临床因素的关系。103例(14.4%)发现同时性食管鳞状细胞癌(ESCC),与较低绝对淋巴细胞计数(p<0.001)、较高NLR(p=0.044)和较低LMR(p=0.001)相关,而与PLR无关(p=0.49)。LMR<4(OR 2.22;95%CI 1.27-3.88,p=0.005)、饮酒(OR 4.19;95%CI 1.47-11.91,p=0.007)、肿瘤位于咽部(OR 1.68;95%CI 1.07-2.64,p=0.025)和低体重指数(OR 0.94;95%CI 0.88-0.99,p=0.039)是发生同时性ESCC的危险因素。低LMR与总生存期下降显著相关(p<0.0001),在同时性和非同时性组中均如此。多因素分析显示,LMR<4(HR 1.97;95%CI 1.38-2.81,p<0.001)、低BMI(HR 0.96;95%CI 0.93-0.99,p=0.044)和存在同时性ESCC(HR 1.56;95%CI 1.10-2.22,p=0.013)是HNSCC患者的独立预后因素。结论:将LMR与其他已识别的危险因素(如饮酒、肿瘤位于咽部和低BMI)结合,可能建立更高效的HNSCC患者食管探查筛查方案。LMR的意义还提示抗癌免疫可能在多原发癌发生的癌化过程中发挥作用,免疫治疗未来可能有预防或作为同时性鳞状细胞癌辅助治疗的潜力。
要点
- HNSCC患者中14.4%(103/717)发现同时性ESCC。
- LMR<4、饮酒、肿瘤位于咽部和低BMI是同时性ESCC的危险因素。
- LMR<4、低BMI和同时性ESCC是HNSCC患者的独立预后因素。
核心结论
- 将LMR与其他已识别的危险因素(饮酒、肿瘤位于咽部、低BMI)结合,可能建立更高效的HNSCC患者食管探查筛查方案。
- LMR的意义提示抗癌免疫可能在多原发癌发生的癌化过程中发挥作用,免疫治疗未来可能有预防或作为同时性鳞状细胞癌辅助治疗的潜力。
研究设计与样本
- 连续纳入717例新诊断HNSCC并接受治疗前食管内镜筛查的患者。
- 计算并分析治疗前NLR、LMR和PLR,并与临床因素比较。
主要发现
- 103例(14.4%)发现同时性ESCC,与较低绝对淋巴细胞计数(p<0.001)、较高NLR(p=0.044)和较低LMR(p=0.001)相关,而与PLR无关(p=0.49)。
- ROC曲线验证存在同时性ESCC的最佳截断值:NLR为2.5,LMR为4.0。
- 多因素logistic回归显示LMR<4(OR 2.22;95%CI 1.27-3.88,p=0.005)、饮酒(OR 4.19;95%CI 1.47-11.91,p=0.007)、肿瘤位于咽部(OR 1.68;95%CI 1.07-2.64,p=0.025)和低BMI(OR 0.94;95%CI 0.88-0.99,p=0.039)是发生同时性ESCC的危险因素。
- 低LMR与总生存期下降显著相关(p<0.0001),在同时性和非同时性组中均如此。
- 多因素分析显示LMR<4(HR 1.97;95%CI 1.38-2.81,p<0.001)、低BMI(HR 0.96;95%CI 0.93-0.99,p=0.044)和存在同时性ESCC(HR 1.56;95%CI 1.10-2.22,p=0.013)是HNSCC患者的独立预后因素。
关键数值与推荐
- LMR<4的OR为2.22(95%CI 1.27-3.88,p=0.005),作为同时性ESCC的危险因素。
- 饮酒的OR为4.19(95%CI 1.47-11.91,p=0.007),作为同时性ESCC的危险因素。
- 肿瘤位于咽部的OR为1.68(95%CI 1.07-2.64,p=0.025),作为同时性ESCC的危险因素。
- 低BMI的OR为0.94(95%CI 0.88-0.99,p=0.039),作为同时性ESCC的危险因素。
- LMR<4的HR为1.97(95%CI 1.38-2.81,p<0.001),低BMI的HR为0.96(95%CI 0.93-0.99,p=0.044),同时性ESCC的HR为1.56(95%CI 1.10-2.22,p=0.013),均为HNSCC患者的独立预后因素。
临床怎么用
- 将LMR与其他已识别的危险因素(饮酒、肿瘤位于咽部、低BMI)结合,可能建立更高效的HNSCC患者食管探查筛查方案。
- LMR的意义提示抗癌免疫可能在多原发癌发生的癌化过程中发挥作用,免疫治疗未来可能有预防或作为同时性鳞状细胞癌辅助治疗的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) frequently develop synchronous esophageal cancer (ESCC), but there is a lack of clinical predictors. The neutrophil to lymphocyte (NLR), platelet to lymphocyte (PLR), and lymphocyte to monocyte ratios (LMRs), reflect the balance between pro-cancer inflammation and anti-cancer immune responses, but their role in HNSCC and synchronous cancer remain uncertain. METHOD: The study consecutively enrolled a total of 717 patients with newly diagnosed HNSCC who received pre-treatment esophageal endoscopic screening. The pretreatment NLR, LMR and PLRs were calculated and analyzed in comparison with the clinical factors. RESULTS: A total of 103 patients (14.4%) were found to have synchronous ESCCs, and were associated with a significantly lower absolute lymphocyte count (p < 0.001), higher NLRs (p = 0.044) and lower LMRs (p = 0.001), but not PLRs (p = 0.49). The ROC curve for the presence of synchronous ESCC verified the optimal cutoff value as 2.5 for NLRs and 4.0 for LMRs. Multivariable logistic regression revealed that a LMR <4 (OR 2.22; 95% CI 1.27-3.88, p = 0.005), alcohol consumption (OR 4.19; 95% CI 1.47-11.91, p = 0.007), tumor location over the pharynx (OR 1.68; 95% CI 1.07-2.64, p = 0.025), and low body mass index (OR 0.94; 95% CI 0.88-0.99, p = 0.039) were risk factors for developing synchronous ESCC. A low-LMR was significantly associated with decreases in overall survival (p < 0.0001), in both synchronous and non-synchronous groups. Multivariate analysis demonstrated that LMR <4 (HR 1.97; 95% CI 1.38-2.81, p < 0.001), a low-BMI (HR 0.96; 95% CI 0.93-0.99, p = 0.044) and presence of synchronous ESCC (HR 1.56; 95% CI 1.10-2.22, p = 0.013) were independent prognostic factors for HNSCC patients. CONCLUSION: Incorporation of LMR into other identified risk factors, such as alcohol consumption, tumor location over pharynx, and low-BMI, may establish a more efficient screening program for esophageal exploration in HNSCC patients. The significances of LMR also suggest that anti-cancer immunity may play a role in the filed cancerization to initiate multiple cancers, and the immunotherapy may have potentials for prevention or as an adjuvant treatment for synchronous SCC in the future.
引用
- Wang CC, Hsu MH, Lee CT, et al. Prognostic significances of systemic inflammatory response markers in patients with synchronous esophageal and head and neck cancers. Head Neck. 2024. PMID: 38344911. doi:10.1002/hed.27677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。